Skip to main content

Table 2 Histopathological, IHC results, and molecular subgroups

From: Medulloblastoma: clinicopathological parameters, risk stratification, and survival analysis of immunohistochemically validated molecular subgroups

 

No. (%)

Histopathological types

 

Classic medulloblastoma

14 (35%)

Desmoplastic/nodular medulloblastoma

10 (25%)

Large cell/anaplastic medulloblastoma

16 (40%)

Degree of anaplasia

 

Slight anaplasia

7 (17.5%)

Moderate anaplasia

15 (37.5%)

Severe anaplasia

18 (45%)

β-catenin expression

 

Positive nuclear expression

4 (10%)

Negative both nuclear and cytoplasmic expression

4 (10%)

Cytoplasmic expression

32 (80%)

GAB1 expression

 

Negative

28 (70%)

Positive

12 (30%)

Molecular subgroups

 

WNT

4 (10%)

SHH

12 (30%)

Non-WNT/SHH

24 (60%)